The medication carries a risk of thyroid C-cell tumors and is contraindicated in patients with a personal or family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
The drugs work by mimicking a hormone in the body called GLP-1 that triggers an increase in the production of insulin, slows the rate at which food is digested in the stomach, and reduces appetite
Frequently asked questions about GLP-1s What happens if I stop taking a GLP-1
compounding pharmacies Ongoing Support : Stay connected with unlimited virtual provider visits throughout your journeyall included in your $219/month flat rate Track Progress : Work with our team to monitor your results, adjust your dose as needed, and optimize your outcomes The Bottom Line Both semaglutide and tirzepatide represent significant advances in medical weight management
The biggest practical difference is price
Data from the STEP trial program shows that patients who discontinue semaglutide commonly regain a substantial portion of the weight they lost, without a specific number we can promise for any individual
:max_bytes(150000):strip_icc()/VWH-AmeliaManley-OzempicvsWegovyvsMounjaro-dc80b8c8de6243ec9b984cd4b5db5db4.jpg)
